Morgan Stanley’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-196
| Closed | -$880 | – | 8093 |
|
|
2023
Q4 | $880 | Buy |
196
+98
| +100% | +$344 | ﹤0.01% | 7219 |
|
|
2023
Q3 | $593 | Sell |
98
-1
| -1% | -$10 | ﹤0.01% | 7291 |
|
|
2023
Q2 | $1.21K | Hold |
99
| – | – | ﹤0.01% | 7272 |
|
|
2023
Q1 | $1.42K | Sell |
99
-8
| -7% | -$150 | ﹤0.01% | 7295 |
|
|
2022
Q4 | $1.6K | Sell |
107
-20
| -16% | -$576 | ﹤0.01% | 7407 |
|
|
2022
Q3 | $5K | Sell |
127
-1,121
| -90% | -$64.4K | ﹤0.01% | 7265 |
|
|
2022
Q2 | $95K | Buy |
1,248
+1,027
| +465% | +$90.1K | ﹤0.01% | 6304 |
|
|
2022
Q1 | $10K | Sell |
221
-3,984
| -95% | -$239K | ﹤0.01% | 7412 |
|
|
2021
Q4 | $294K | Buy |
4,205
+3,915
| +1,350% | +$422K | ﹤0.01% | 5857 |
|
|
2021
Q3 | $42K | Buy |
290
+184
| +174% | +$55.8K | ﹤0.01% | 6796 |
|
|
2021
Q2 | $64K | Buy |
106
+15
| +16% | +$9.79K | ﹤0.01% | 6562 |
|
|
2021
Q1 | $63K | Buy |
+91
| New | +$65.4K | ﹤0.01% | 6250 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6772 |
|
|
2020
Q1 | – | Sell |
-3
| Closed | -$2.14K | – | 6762 |
|
|
2019
Q4 | $2K | Sell |
3
-6
| -67% | -$5.11K | ﹤0.01% | 6519 |
|
|
2019
Q3 | $8K | Hold |
9
| – | – | ﹤0.01% | 6275 |
|
|
2019
Q2 | $8K | Hold |
9
| – | – | ﹤0.01% | 6199 |
|
|
2019
Q1 | $8K | Hold |
9
| – | – | ﹤0.01% | 6242 |
|
|
2018
Q4 | $7K | Hold |
9
| – | – | ﹤0.01% | 6247 |
|
|
2018
Q3 | $6K | Hold |
9
| – | – | ﹤0.01% | 6419 |
|
|
2018
Q2 | $8K | Sell |
9
-2
| -18% | -$1.7K | ﹤0.01% | 6358 |
|
|
2018
Q1 | $9K | Sell |
11
-9
| -45% | -$7.37K | ﹤0.01% | 6294 |
|
|
2017
Q4 | $16K | Hold |
20
| – | – | ﹤0.01% | 6137 |
|
|
2017
Q3 | $17K | Sell |
20
-2
| -9% | -$1.89K | ﹤0.01% | 6061 |
|
|
2017
Q2 | $25K | Sell |
22
-59
| -73% | -$78.4K | ﹤0.01% | 6042 |
|
|
2017
Q1 | $141K | Buy |
81
+68
| +523% | +$125K | ﹤0.01% | 5476 |
|
|
2016
Q4 | $9K | Buy |
13
+1
| +8% | +$898 | ﹤0.01% | 6181 |
|
|
2016
Q3 | $11K | Hold |
12
| – | – | ﹤0.01% | 6094 |
|
|
2016
Q2 | $14K | Buy |
+12
| New | +$13.2K | ﹤0.01% | 5969 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6764 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 6840 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 6758 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 6586 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 6497 |
|
|
2014
Q4 | – | Sell |
-1
| Closed | -$5.8K | – | 6500 |
|
|
2014
Q3 | $6K | Buy |
+1
| New | +$8.61K | ﹤0.01% | 6304 |
|
Morgan Stanley's MDVL Position: Q1 2024 in Review
Morgan Stanley sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q1 2024, closing a stake of 196 shares — an estimated $880 sold.
Morgan Stanley first reported a position in MDVL in Q3 2014 and held it in 28 quarters. The position peaked at $294K in Q4 2021. 1 fund tracked by Wall St. Rank holds MDVL as of Q1 2024.
- Morgan Stanley reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Morgan Stanley sold 196 MedAvail Holdings, Inc. Common Stock shares in Q1 2024, an estimated $880.
- Morgan Stanley first reported a position in MedAvail Holdings, Inc. Common Stock in Q3 2014 and held it in 28 quarters.
- Morgan Stanley's MedAvail Holdings, Inc. Common Stock position peaked at $294K in Q4 2021.
- 1 fund tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q1 2024.
Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.